Risk perception after genetic counseling in patients with increased risk of cancer.
BACKGROUND
Counselees are more aware of genetics and seek information, reassurance, screening and genetic testing. Risk counseling is a key component of genetic counseling process helping patients to achieve a realistic view for their own personal risk and therefore adapt to the medical, psychological and familial implications of disease and to encourage the patient to make informed choices 12.The aim of this study was to conceptualize risk perception and anxiety about cancer in individuals attending to genetic counseling.


METHODS
The questionnaire study measured risk perception and anxiety about cancer at three time points: before and one week after initial genetic counseling and one year after completed genetic investigations. Eligibility criteria were designed to include only index patients without a previous genetic consultation in the family. A total of 215 individuals were included. Data was collected during three years period.


RESULTS
Before genetic counseling all of the unaffected participants subjectively estimated their risk as higher than their objective risk. Participants with a similar risk as the population overestimated their risk most. All risk groups estimated the risk for children's/siblings to be lower than their own. The benefits of preventive surveillance program were well understood among unaffected participants.The difference in subjective risk perception before and directly after genetic counseling was statistically significantly lower in all risk groups. Difference in risk perception for children as well as for population was also statistically significant. Experienced anxiety about developing cancer in the unaffected subjects was lower after genetic counseling compared to baseline in all groups. Anxiety about cancer had clear correlation to perceived risk of cancer before and one year after genetic investigations.The affected participants overestimated their children's risk as well as risk for anyone in population. Difference in risk perception for children/siblings as for the general population was significant between the first and second measurement time points. Anxiety about developing cancer again among affected participants continued to be high throughout this investigation.


CONCLUSIONS
The participant's accuracy in risk perception was poor, especially in low risk individuals before genetic counseling. There was a general trend towards more accurate estimation in all risk groups after genetic counseling. The importance of preventive programs was well understood. Cancer anxiety was prevalent and associated with risk perception, but decreased after genetic counseling.1 National Society of Genetic Counselors (2005), Genetic Counseling as a Profession. Available at http://www.nsgc.org/about/definition.cfm (accessed November 25th 2007)2 Julian-Reynier C., Welkenhuysen M-, Hagoel L., Decruyenaere M., Hopwood P. (2003) Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J of Human Genetics 11, 725736.
Rantala
Johanna
J
Department of Clinical Genetics, Karolinska University Hospital, L5:03, S-17176 Stockholm, Sweden. johanna.rantala@ki.se
Platten
Ulla
U
Lindgren
Gunilla
G
Nilsson
Bo
B
Arver
Brita
B
Lindblom
Annika
A
Brandberg
Yvonne
Y
Br J Cancer. 1993 Mar;67(3):612-4
8439512
Psychooncology. 1998 Sep-Oct;7(5):402-12
9809331
Fam Cancer. 2001;1(1):31-7
14574013
J Clin Oncol. 2004 May 1;22(9):1736-42
15117997
J Med Genet. 2002 Jul;39(7):526-30
12114489
Eur J Hum Genet. 2003 Oct;11(10):725-36
14512961
Fam Cancer. 2003;2(3-4):159-68
14707527
J Genet Couns. 2005 Feb;14(1):55-69
15789156
J Natl Cancer Inst. 2000 Aug 16;92(16):1345-51
10944557
Br J Cancer. 1994 Nov;70(5):934-8
7947100
J Clin Epidemiol. 2002 Jul;55(7):665-75
12160914
J Natl Cancer Inst Monogr. 1999;(25):44-51
10854457
World J Surg. 1997 Feb;21(2):205-9
8995080
Health Psychol. 1996 Nov;15(6):423-9
8973921
Br J Surg. 1990 Dec;77(12):1367-70
2276021
J Natl Cancer Inst Monogr. 1999;(25):59-66
10854459
Community Genet. 2003;6(4):214-23
15331867
Genet Couns. 2000;11(2):127-46
10893664
Am J Gastroenterol. 2001 Oct;96(10):2992-3003
11693338
Eur J Cancer. 2004 Feb;40(3):365-74
14746854
Fam Cancer. 2006;5(1):61-75
16528610
J Clin Oncol. 2000 Jun;18(11):2250-7
10829045
Gastroenterology. 1995 Sep;109(3):1015-7
7657089
Community Genet. 1998;1(2):78-83
11657631
Br J Cancer. 2002 Jan 7;86(1):43-50
11857010
Cancer Detect Prev. 2007;31(6):457-64
18061369
Br J Cancer. 1998;77(1):174-9
9459165
Ann Intern Med. 1993 May 15;118(10):785-90
8470852
J Genet Couns. 2007 Apr;16(2):211-22
17279329
Genet Test. 2005 Spring;9(1):54-65
15857188
Fam Cancer. 2005;4(2):151-61
15951967
Eur J Cancer. 2004 Sep;40(14):2056-63
15341979
J Genet Couns. 2005 Apr;14(2):119-32
15959643
J Clin Oncol. 1998 May;16(5):1650-4
9586874
Br J Surg. 1976 Jan;63(1):13-18
1267868
N Engl J Med. 1994 Dec 22;331(25):1669-74
7969357
J Med Genet. 2002 Sep;39(9):689-94
12205115
Eur J Hum Genet. 2008 Apr;16(4):445-52
18197196